Copyright
©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 111414
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.111414
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.111414
Table 1 Changes of lipid profile during hospitalization
| March 1, 2024 | February 22, 2024 | February 17, 2024 | February 2, 2024 | January 30, 2024 | January 26, 2024 | January 22, 2024 | January 15, 2024 | January 4, 2024 | November 25, 2023 | |
| TC (mmol/L) | 47.28 | 50.23 | 50.42 | 50.72 | 51.28 | 51.03 | 51.46 | 50.59 | 46.57 | 14.35 |
| TG (mmol/L) | 4.74 | 8.99 | 4.09 | 5.55 | 5.59 | 9.26 | 4.01 | 2.54 | 8.36 | 2.41 |
| HDL-C (mmol/L) | 6.07 | 7.23 | 7.4 | 7.91 | 7.32 | 7.87 | 8.02 | 7.92 | 7.15 | - |
| LDL-C (mmol/L) | 36.71 | 37.47 | 37.79 | 37.72 | 38.34 | 37.02 | 37.15 | 36.75 | 35.3 | - |
- Citation: Xu MJ, Wei X, Lu Y, Sun L, Xie Y, Li MH. Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report. World J Hepatol 2025; 17(12): 111414
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/111414.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.111414